Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (16)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Biancone, L.
Right arrow Articles by Camussi, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Biancone, L.
Right arrow Articles by Camussi, G.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrology Dialysis Transplantation, Vol 13, Issue 3 716-722, Copyright © 1998 by Oxford University Press


ORIGINAL ARTICLES

Expression of inducible lymphocyte costimulatory molecules in human renal allograft

L Biancone, G Segoloni, E Turello, D Donati, B Bussolati, G Piccoli and G Camussi
Cattedra di Nefrologia, Dipartimento di Scienze Cliniche e Biologiche, Universita di Pavia, Varese, Italy; Laboratorio di Immunopatologia, Catteedra di Nefrologia, Dipartimento di Discipline Medico-Chirurgiche, Corso Dogliotti 14, I-10126 Torino, Italy; Corresponding author

Background: CTLA-4/CD28-B7 and CD40-CD40L interactions constitute two key costimulatory pathways in lymphocyte signalling during experimental allograft rejection. Studies on the expression of these molecules in human transplant rejection are still lacking. Methods: The immunohistochemical study was performed on renal biopsies obtained for various clinical complications from 25 renal transplant patients. Expression of B7-1 and B7-2 and their counter-receptor CTLA-4, and of CD40 and its counter-receptor CD40L was examined. Results: In acute rejection a focal intense infiltration of B7-1+ and B7-2+ cells (mainly CD20- CD14+) and of CTLA-4+ T lymphocytes (mainly CD8+) was present. In contrast, CD40 and CD40L were rarely expressed. Accumulations of T lymphocytes were found in the interstitium in the same area containing B7-1+ and B7-2+ cells. The scattered CD40L+ cells found in the T-cell infiltrate exhibited the CD4+ phenotype. In chronic rejection only a few B7-1+, B7-2+ or CTLA-4+ cells were detectable. In contrast, several CD40L+CD4+ cells were present both in the interstitium and in glomeruli. Moreover, an intense expression of CD40 on the endothelium was observed. In patients with cyclosporin nephrotoxicity cells positive for B7-1, B7-2, CTLA-4, CD40, or CD40L were absent. Conclusions: These results demonstrate a differential expression of costimulatory molecules in renal biopsies of allograft recipients undergoing acute or chronic rejection. Moreover, their detection may prove useful to discriminate rejection from cyclosporin nephrotoxicity. Key words: transplantation, rejection, costimulatory molecules
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Immunol.Home page
H. Xu, K. K. Dhanireddy, and A. D. Kirk
Human Monocytes as Intermediaries between Allogeneic Endothelial Cells and Allospecific T Cells: A Role for Direct Scavenger Receptor-Mediated Endothelial Membrane Uptake in the Initiation of Alloimmunity
J. Immunol., January 15, 2006; 176(2): 750 - 761.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Russo, B. Bussolati, I. Deambrosis, F. Mariano, and G. Camussi
Platelet-Activating Factor Mediates CD40-Dependent Angiogenesis and Endothelial-Smooth Muscle Cell Interaction
J. Immunol., November 15, 2003; 171(10): 5489 - 5497.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
P. Trzonkowski, J. Mysliwska, A. Debska-Slizien, E. Bryl, D. Rachon, A. Mysliwski, and B. Rutkowski
Long-term therapy with recombinant human erythropoietin decreases percentage of CD152+ lymphocytes in primary glomerulonephritis haemodialysis patients
Nephrol. Dial. Transplant., June 1, 2002; 17(6): 1070 - 1080.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
A. M. WOLTMAN, S. DE HAIJ, J. G. BOONSTRA, S. J.P. GOBIN, M. R. DAHA, and C. V. KOOTEN
Interleukin-17 and CD40-Ligand Synergistically Enhance Cytokine and Chemokine Production by Renal Epithelial Cells
J. Am. Soc. Nephrol., November 1, 2000; 11(11): 2044 - 2055.
[Abstract] [Full Text]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.